EGF |
Modulates growth and differentiation of oral cancer cells |
Bernades et al. [43] |
ErbB proteins (EGFR, ErbB2, ErbB3, ErbB4) |
Progression and pathogenesis of OSCC |
Bernades et al. [43] |
GRB2 |
Overexpression is correlated with lymph node metastasis |
Li et al. [44] |
Shc |
Activation of Shc results in couple β6 signaling to the Raf-ERK/MAPK pathway |
Li et al. [45] |
SOS1 |
Useful biomarker in OSCC |
Baltanas et al. [46] |
Ras |
Ras mutations confer therapeutic resistance |
Batta et al. [47] |
Raf |
Oral cancer behaves similarly like other cancer in terms of perturbations in Raf kinase inhibitor protein |
Hallums et al. [48] |
MEK/ERK |
Related to chemoresistance in oral cancer |
Kashyap et al. [49] |
MAPK |
Promotes tumour cell proliferation and anti-apoptosis |
Peng et al. [50] |
PI3K/Akt/mTOR |
Overexpression related to poor prognosis of oral cancer |
Harsha et al. [51] |
PTEN |
Epigenetic biomarker in OSCC |
Sushma et al. [52] |
PDK1 |
Targeting PDK1 sensitizes NOTCH1 to PI3K/mTOR pathway |
Sambandam et al. [53] |
4E-BP |
Reactivated by mTOR inhibition in OSCC |
Wang et al. [54] |
Cyclin D |
Early biomarker in oral cancer |
Ramakrishna et al. [55] |
CDK4, CDK6 |
The index scores of CDK4, CDK6, and cyclin D1 are associated with the transformation from pre-cancer to oral cancer stage |
Kujan et al. [56] |
Cyclin E |
Related to progression of cancer |
Moharil et al. [57] |
Cyclin A, Cyclin B |
Prognostic significance in OSCC |
Monteiro et al. [58] |
CDK1, CDK2 |
CDK1 serve as a prognostic marker and malignant degree for the survival of OSCC patients. CDK2 overexpression serve as a prognostic marker of OSCC |
Chen et al. [59]; Mihara et al. [60] |
Pocket proteins (RB, RBL1/p107, RBL2/p130) |
Suppress OSCC |
Shin et al. [61] |
ATM and ATR |
Related to radiosensitivity in OSCC |
Parikh et al. [62] |
p53 |
Inactivated in OSCC resulting in prolonged cell cycle |
Ragos et al. [63] |
CIP/KIP family (p21, p27, p57) |
Cell cycle regulators |
Perez-Sayans et al. [64] |
INK4 family (p15, p16, p18, p19) |
Related to transformation from precancer to oral cancer stage |
Agarwal et al. [65] |